Skip to main content
logo
ABL Bio Inc. (KOSDAQ:298380)
South Korea flag South Korea · Delayed Price · Currency is KRW
100,300
+400 (0.40%)
Sep 18, 2025, 3:30 PM KST

Revenue by Product

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
Bio-Protein Recombinant Medicines
33.40B
Log In
Log In
Log In
Log In
Upgrade
Bio-Protein Recombinant Medicines Growth
-49.04%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
FY 2024FY 2023FY 2022FY 2021FY 20202017 - 2019
Period Ending
Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2017 - 2019
United States
33.10B
Log In
Log In
Log In
Log In
Upgrade
United States Growth
-47.91%
Log In
Log In
Log In
Log In
Upgrade
South Korea
300.00M
Log In
Log In
Log In
Log In
Upgrade
South Korea Growth
-84.97%
Log In
Log In
Log In
Log In
Upgrade
China
-
Log In
Log In
Log In
Log In
Upgrade